Range
- - -
Vol / Avg.
-/216.6K
Div / Yield
-
52 Wk
2.18 - 7.25
Mkt Cap
29.8M
Payout Ratio
-
Open
-
P/E
-
Shares
10.1M
Outstanding
10.1M
Total Float
5M
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-08
REV
Q1 2021Est.ActualSurprise
EPS-0.230
REV0

Related Companies

TickerCompanyChg %Mkt Cap
PRFXPainReform-2.36%29.8M

PainReform Frequently Asked Questions

Q

How do I buy PainReform (PRFX) stock?

A

You can purchase shares of PainReform (NASDAQ: PRFX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PainReform's (PRFX) competitors?

A

There are no as such competitors for PainReform.

Q

What is the target price for PainReform (PRFX) stock?

A

There is no analysis for PainReform

Q

Current Stock Price for PainReform (PRFX)?

A

The stock price for PainReform (NASDAQ: PRFX) is $2.96 last updated Mon Jun 21 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does PainReform (PRFX) pay a dividend?

A

There are no upcoming dividends for PainReform.

Q

When is PainReform (NASDAQ:PRFX) reporting earnings?

A
PainReform’s Q2 earnings are confirmed for after-market on August 8, 2021.
Q

Is PainReform (PRFX) going to split?

A

There is no upcoming split for PainReform.

Q

What sector and industry does PainReform (PRFX) operate in?

A

PainReform is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.